Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11857697
Compositions and methods for obtaining 3-dimensional lung-like epithelium and related uses thereof
granted -
US 11859190
Methods and compositions for regulation of transgene expression
granted -
US 11851680
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11851655
Compositions and methods for modulating apolipoprotein (a) expression
granted -
US 11844765
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11845937
RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use
granted -
US 11845965
Regulation of gene expression using engineered nucleases
granted -
US 11845778
Prefusion PIV F immunogens and their use
granted -
US 11840688
Compositions and methods for inhibiting gene expression of Hif2alpha
granted -
US 11840686
Modulation of prekallikrein (PKK) expression
granted -
US 11840690
Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat
granted -
US 11839631
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
granted -
US 11833211
Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
granted -
US 11834688
Ligase fusion proteins and application thereof
granted -
US 11833168
Compounds and methods for increasing STMN2 expression
granted -
US 11833221
Oligomeric compounds for reducing DMPK expression
granted -
US 11834660
Compositions for modulating Ataxin 2 expression
granted -
US 11826392
Purification method of fungal cell wall composition
granted -
US 11827691
Serpin fusion polypeptides and methods of use thereof
granted -
US 11819554
Compositions and methods for modulating FMR1 expression
granted -
US 11807661
Antibody fusion protein and related compositions for targeting cancer
granted -
US 11806318
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted -
US 11786554
Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene
granted -
US 11788077
Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted